Cancer and Treatment Distress (CTXD) measure

The CTXD is designed to assess distress specific to cancer and its treatment, as distinct from general anxiety or depression. It has been tested with hematopoietic stem cell transplant recipients (autologous and allogeneic) at multiple time points with adequate to excellent reliabilities. The measure has also been used with well over 1000 non-transplant cancer patients.

The CTXD comes in Patient and Caregiver versions. The Caregiver version (CG-CTXD) uses similar items as the one used for patients but also includes items specific to caregivers.

Available Licenses

To license this product, please complete, sign and return the copyright permission to Further instructions are provided therein.

Please Note: Non-commercial use is free for academic and non-profit users.  For any commercial use, please contact for additional information.

Credit Line for Acknowledgement

When using the CTXD, please include “Copyright Fred Hutchinson Cancer Center. All Rights Reserved” and credit/attribution in publications to Dr. Karen Syrjala, according to accepted publications standards.

Questions About this Product?

Contact the Business Development team